Related Experiment Video
Updated: Jun 23, 2026

06:26
Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
Published on: July 28, 2023
T-cell assay as a diagnostic tool for tuberculosis.
A Warier1, S Gunawathi, Venkatesh
1Department of Child Health, Low Cost Effective Care Unit and Department of Community Health, Christian Medical College, Vellore, India.
Indian Pediatrics
|May 12, 2009
Summary
The whole blood interferon-gamma release assay (ELISPOT) shows high specificity (97.9%) for diagnosing childhood tuberculosis. While sensitivity is moderate (53.3%), it can be a valuable tool for pediatric TB diagnosis.
Area of Science:
- Pediatric Infectious Diseases
- Immunological Assays
- Mycobacterium tuberculosis Diagnostics
Background:
- Childhood tuberculosis diagnosis presents challenges.
- Accurate diagnostic tools are crucial for timely treatment.
- Interferon-gamma release assays (IGRAs) are explored for TB detection.
Purpose of the Study:
- To evaluate the specificity and sensitivity of the whole blood interferon-gamma release assay (ELISPOT) for diagnosing tuberculosis in children.
- To assess the utility of the ELISPOT test as an aid in pediatric TB diagnosis.
Main Methods:
- A case-control study involving 96 pediatric patients with diagnosed tuberculosis and 47 age/sex-matched controls.
- Testing utilized a whole blood interferon-gamma assay (ELISPOT).
- Analysis excluded 23 invalid test results.
Main Results:
- The ELISPOT test demonstrated high specificity at 97.9%.
- Sensitivity was 53.3% in confirmed childhood tuberculosis cases.
- Sensitivity was lower in other patient groups.
Conclusions:
- The whole blood ELISPOT assay is a highly specific diagnostic aid for childhood tuberculosis.
- The test's moderate sensitivity suggests it should be used alongside other diagnostic methods.
- Further research may refine IGRA utility in pediatric TB.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
